Novo Nordisk Foundation
The Novo Nordisk Foundation is an international foundation focusing on medical treatment and research. The foundation is the primary owner of Novo Nordisk A/S and NovoZymes A/S through its subsidiary company called Novo A/S.[1] The Foundation hands out more than 300 million US dollars each year to research within the fields of Life- and Bioscience.[2]
References
This article is issued from Wikipedia - version of the 11/28/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.